Description

Pinealon is a short synthetic tripeptide (Glu–Asp–Arg) developed as part of Russian bioregulator research led by Dr. Vladimir Khavinson. It is derived from naturally occurring peptide fragments associated with brain tissue and is classified as a brain-specific bioregulator peptide.

Unlike conventional nootropics that stimulate neurotransmitter activity for immediate cognitive effects, Pinealon is believed to work at the cellular level. Research suggests it may influence gene expression related to neuronal metabolism, oxidative stress resistance, and brain plasticity. This regulatory mechanism is thought to support neuronal repair, cellular stability, and long-term cognitive resilience.

Pinealon has been studied in the context of:

Age-related cognitive decline

Neuroprotection

Memory and focus support

Central nervous system regulation

Oxidative stress modulation

Animal and early human research indicate potential benefits in supporting brain tissue integrity and slowing functional decline associated with aging.